StreetInsider

• Log in to your account:

  
  Log in
• Signup
• Home
• EPS Insider
• Event Calendar
• Conferences
• Classic Site

Upgrade to SI Premium - Free Trial

Seres Therapeutics (MCRB)

Form EFFECT Seres Therapeutics, Inc. August 24, 2026 6:05 AM - SEC Filing Form 4 Seres Therapeutics, Inc. For: Aug 15 Filed by: Brady Kelly August 18, 2026 5:33 PM - SEC Filing Form 4 Seres Therapeutics, Inc. For: Aug 15 Filed by: Shaff Eric D. August 18, 2026 5:28 PM - SEC Filing Form 4 Seres Therapeutics, Inc. For: Aug 15 Filed by: Henn Matthew R August 18, 2026 5:26 PM - SEC Filing Form 4 Seres Therapeutics, Inc. For: Aug 15 Filed by: DesRosier Thomas August 18, 2026 5:23 PM - SEC Filing Seres Therapeutics (MCRB) files $300M mixed shelf August 13, 2026 4:36 PM - StreetInsider Form S-3 Seres Therapeutics, Inc. August 13, 2026 4:35 PM - SEC Filing Form 10-Q Seres Therapeutics, Inc. For: Jun 30 August 5, 2026 10:31 AM - SEC Filing Seres Therapeutics (MCRB) Tops Q2 EPS by 277c August 5, 2026 7:09 AM - StreetInsider Form 8-K Seres Therapeutics, Inc. For: Aug 05 August 5, 2026 7:05 AM - SEC Filing Seres Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates, Including Further Action to Reduce Ongoing Facilities Costs August 5, 2026 7:01 AM - Globe NewsWire Form 8-K Seres Therapeutics, Inc. For: Jul 31 August 4, 2026 4:04 PM - SEC Filing Form 424B5 Seres Therapeutics, Inc. August 4, 2026 4:02 PM - SEC Filing Form 4 Seres Therapeutics, Inc. For: Jul 08 Filed by: Graves Kurt July 10, 2026 4:15 PM - SEC Filing Form 4 Seres Therapeutics, Inc. For: Jul 08 Filed by: Dere Willard H July 10, 2026 4:15 PM - SEC Filing Form 4 Seres Therapeutics, Inc. For: Jul 08 Filed by: Henn Matthew R July 10, 2026 4:15 PM - SEC Filing Form 4 Seres Therapeutics, Inc. For: Jul 08 Filed by: Shaff Eric D. July 10, 2026 4:15 PM - SEC Filing Form 4 Seres Therapeutics, Inc. For: Jul 08 Filed by: Kender Richard N July 10, 2026 4:15 PM - SEC Filing Form 4 Seres Therapeutics, Inc. For: Jul 08 Filed by: Ausiello Dennis A July 10, 2026 4:15 PM - SEC Filing Form 4 Seres Therapeutics, Inc. For: Jul 08 Filed by: Thorell Marella July 10, 2026 4:15 PM - SEC Filing Form 4 Seres Therapeutics, Inc. For: Jul 08 Filed by: Brady Kelly July 10, 2026 4:15 PM - SEC Filing Form 4 Seres Therapeutics, Inc. For: Jul 08 Filed by: Fraser Claire July 10, 2026 4:15 PM - SEC Filing Form 4 Seres Therapeutics, Inc. For: Jul 08 Filed by: Rosiello Robert L. July 10, 2026 4:15 PM - SEC Filing Form 4 Seres Therapeutics, Inc. For: Jul 08 Filed by: DesRosier Thomas July 10, 2026 4:15 PM - SEC Filing Form 4 Seres Therapeutics, Inc. For: Jul 08 Filed by: Berenson Stephen July 10, 2026 4:15 PM - SEC Filing Form S-8 Seres Therapeutics, Inc. July 9, 2026 4:06 PM - SEC Filing Form 8-K Seres Therapeutics, Inc. For: Jul 08 July 8, 2026 4:05 PM - SEC Filing Form 8-K Seres Therapeutics, Inc. For: Jul 08 July 8, 2026 8:00 AM - SEC Filing Seres reports early trial data for SER-155 in cancer therapy side effect July 8, 2026 7:01 AM - StreetInsider Seres Therapeutics Announces Early Clinical Data Showing Potential for SER-155 in Immune Checkpoint Inhibitor-Related Enterocolitis (irEC), a Frequent Adverse Reaction That Forces Many Patients to Hal July 8, 2026 7:00 AM - Globe NewsWire Form 4 Seres Therapeutics, Inc. For: Jul 01 Filed by: Berenson Stephen July 2, 2026 6:13 PM - SEC Filing Form 4 Seres Therapeutics, Inc. For: Jul 01 Filed by: Rosiello Robert L. July 2, 2026 6:10 PM - SEC Filing Form 4 Seres Therapeutics, Inc. For: Jul 01 Filed by: Ausiello Dennis A July 2, 2026 6:06 PM - SEC Filing Seres Therapeutics to Host Webcast on July 8, 2026, to Discuss Results of Investigator-Sponsored Trial of Seres’ SER-155 in Immune Checkpoint Inhibitor-Related Enterocolitis June 25, 2026 7:00 AM - Globe NewsWire H.C. Wainwright Starts Seres Therapeutics (MCRB) at Buy June 23, 2026 6:07 AM - StreetInsider Full Article List